Research and development
Our ambitious programmes aim to substantially reduce global epidemic and pandemic risk. 成人VR视频鈥檚 priority diseases include Chikungunya, COVID-19, Ebola, Lassa Fever, MERS, Mpox, Nipah, Rift Valley Fever, and novel viral threats with epidemic or pandemic potential (also known as 鈥淒isease X鈥).
Enabling science
From biological standards to preclinical models, 成人VR视频 supports enabling science activities to accelerate the development of safe and effective vaccines.
Vaccine technology
Vaccines are our most potent weapon against infectious diseases and are at the heart of global responses to epidemic and pandemic threats.鈥
Manufacturing and supply chain
成人VR视频 is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.
Our portfolio
Our interactive portfolio provides information on each of the vaccine candidates and other projects that 成人VR视频 has invested in.
Biosecurity
成人VR视频鈥檚 inaugural Biosecurity Strategy鈥攕upported by funding from Global Affairs Canada鈥攁ims to bolster global health security, underscoring its commitment to tackling emerging epidemic and pandemic threats, whether they arise naturally, accidentally or through deliberate misuse.
Call for Proposals
We invite innovators worldwide to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Apply now
Latest News
Top health and science experts join coalition preparing for future pandemic threats
New Mpox vaccine study to launch in outbreak-affected DRC
West African leaders commit to advance Lassa Fever vaccine for the region
